Gainers Buzz: Celanese Corporation, Velti Plc, Rentech, Inc., Endo Health Solutions Inc

Lakeway, TX -- (SBWIRE) -- 02/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Celanese Corporation (NYSE:CE) shares jumped 2.44% and closed at $50.34 in the last trading session. The company will begin trading ex-dividend on February 14, 2013. A cash dividend payment of $0.075 per share is scheduled to be paid on February 28, 2013. Shareholders who purchased CE stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that CE has paid the same dividend.

How Should Investors Trade CE After The Latest Earnings Report? Find Out Here

Velti Plc (NASDAQ:VELT) shares gained 2.43% to $4.22. VELT’s stock was downgraded by research analysts at Wells Fargo from an “outperform” rating to a “market perform” rating in a report released on Jan. 31. Additionally, analysts at Zacks upgraded shares of Velti from an “underperform” rating to a “neutral” rating in a research note to investors on January 15. They now have a $5.30 price target on the stock.

Is VELT a Buy After The Solid Earnings? Get Free Trend Analysis Here

Rentech, Inc. (NYSEAMEX:RTK) shares increased 2.41% and closed at $2.98. The company, on Jan. 22, announced that the Company will hold its 2012 fourth quarter and year end conference call on Tuesday, March 19, 2013 at 11:00 a.m. PST, during which time Rentech's senior management will review the Company's financial results for the period and provide an update on the business.

How Should Investors Trade RTK After The Recent Movement? Find Out Here

Endo Health Solutions Inc (NASDAQ:ENDP) shares jumped 2.41% and closed at $29.38. The company will announce its fourth quarter and full year 2012 financial results after the close of the U.S. financial markets on February 28, 2013 and will host a conference call and webcast at 4:30 p.m. ET that day to discuss these results.

Additionally, the company, on Jan. 30, said it in talks with drug makers about selling itself, Reuters reported, citing people familiar with the matter. The exploratory talks include Warner Chilcott PLC ( WCRX ) and Valeant Pharmaceuticals International Inc. (VRX, VRX.T), but there is no official auction process underway and discussions are at a preliminary stage, according to the report.

Get Latest News, Updates and Reports For Free On ENDP Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.